16 results found.

Glioblastoma Multiforme, Squamous Cell Carcinoma of Head and Neck Clinical Trial using CC-115

Celgene Corporation - Recruiting 18 years or older.
- A Phase 1a/b, Multicenter, Open Label, Dose-Finding Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the Dual DNA-PK and TOR Kinase Inhibitor, CC-115, Administered Orally to Subjects With Advanced Solid Tumors, and Hematologic Malignancies..
CC-115

Osteosarcoma Clinical Trial using Tissue Procurement

Memorial Sloan-Kettering Cancer Center - Recruiting N/A or older.
- Chemotherapy Resistance in Osteogenic Sarcoma and Other Solid Tumors.
Tissue Procurement

Sarcoma Clinical Trial using Ra-223 Dichloride

M.D. Anderson Cancer Center - Recruiting 15 years or older.
- Phase I Dose Escalation of Monthly Intravenous Ra-223 Dichloride in Osteosarcoma.
Ra-223 Dichloride

Bone Cancer, Chondrosarcoma, Ewing's Sarcoma, Osteosarcoma, or Rh Clinical Trial using Feraheme; MR Scan

Stanford University - Recruiting 8 years to 30 years.
- Pilot Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI.
Feraheme; MR Scan

Pulmonary Relapse of Osteosarcoma Clinical Trial using Inhaled Lipid Cisplatin (ILC)

Eleison Pharmaceuticals LLC. - Recruiting 13 years or older.
- Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma.
Inhaled Lipid Cisplatin (ILC)

Recurrent or Refractory Solid Tumors, Ewing Sarcoma, Rhabdomyosar Clinical Trial using MM-398 (Irinotecan Sucrosofate Liposome Injection) plus cyclophosphamide

Merrimack Pharmaceuticals - Recruiting 12 Months to 20 years.
- Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors.
MM-398 (Irinotecan Sucrosofate Liposome Injection) plus cyclophosphamide

Osteosarcoma, or Metastatic Osteosarcoma Clinical Trial using pazopanib

ACORN Research, LLC - Recruiting 16 years or older.
- A Phase II Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung.
pazopanib

Osteosarcoma, or Spindle Cell Sarcoma of Bone Clinical Trial using Glucarpidase; Methotrexate; Folinic Acid

University College, London - Recruiting 5 years to 50 years.
- A Randomised, Cross-over Phase II Study to Investigate the Efficacy and Safety of Glucarpidase for Routine Use After High Dose Methotrexate in Patients With Bone Sarcoma.
Glucarpidase; Methotrexate; Folinic Acid

Osteoarthritis, Osteosarcoma, Scoliosis, or Cerebral Palsy Clinical Trial

University of Florida - Recruiting N/A or older.
- Orthopaedic Data Bank; Collection and Storage of Data Relating to Orthopaedic Disorders.

Osteosarcoma, Ewing's Sarcoma, Rhabdomyosarcoma, Synovial Sarcoma Clinical Trial using Endurance; Strengthening; Stretching; Home exercise program

St. Jude Children's Research Hospital - Recruiting 6 years to 30 years.
- A Pilot Study on the Effects of Preoperative Physical Therapy in Adolescents and Young Adults Diagnosed With a Lower Extremity Malignancy.
Endurance; Strengthening; Stretching; Home exercise program

Osteosarcoma Clinical Trial using High Dose Methotrexate

The Hospital for Sick Children - Recruiting 6 years to 18 years.
- Assessing the Safety, Feasibility, Cost Effectiveness and Patient Satisfaction of Outpatient Administration of High Dose Methotrexate (HD MTX) in Patients With Osteosarcoma.
High Dose Methotrexate

Osteosarcoma Clinical Trial using Thiotepa

Centre Leon Berard - Recruiting 1 year to 50 years.
- Efficacy and Tolerance Adjuvant High-Dose Thiotepa With Peripheral Stem Cell Rescue Associated With Conventional Chemotherapy in Children and Adults With Relapsed Osteosarcoma.
Thiotepa

Glioma, Neuroectodermal Tumors, Primitive, Wilms Tumor, Rhabdomyo Clinical Trial using Metronomic Cyclophosphamide; Thalidomide

Washington University School of Medicine - Recruiting 5 years to 21 years.
- Anti-Angiogenic Therapy After Autologous Stem Cell Rescue (ASCR) for Relapsed and Refractory Pediatric Solid Tumors.
Metronomic Cyclophosphamide; Thalidomide

Sarcoma Clinical Trial using biologic sample preservation procedure

National Cancer Institute (NCI) - Recruiting N/A or older.
- A Children's Oncology Group Protocol for Collecting and Banking Osteosarcoma Specimens.
biologic sample preservation procedure

Osteosarcoma Clinical Trial

Klinikum Stuttgart - Recruiting N/A or older.
- Monitoring the Response of Osteosarcoma Under Neoadjuvant Chemotherapy: The Value of Dynamic Contrast Enhancement and Diffusion-weighted MRI.

Osteosarcoma Clinical Trial using Curcumin powder; Ashwagandha extract

Tata Memorial Hospital - Recruiting 8 years to 65 years.
- Evaluation of Curcumin Formulation, and Ashwagandha Root Powder Extract in the Management of Advanced High Grade Osteosarcoma'.
Curcumin powder; Ashwagandha extract